Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_000014.6(A2M):c.2126-6_2126-2del	A2M|KLRG1		ALPHA-2-MACROGLOBULIN POLYMORPHISM|not provided|not specified	Benign(Last reviewed: Feb 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000402328	12	9246177 - 9246181	12	9093581 - 9093585	402328	390084	rs1799759	NC_000012.12:9093580:TATGGT:T
NM_019112.3(ABCA7):c.2126_2132del (p.Glu709fs)	ABCA7	E709fs	not provided|Alzheimer disease, type 9|Primary degenerative dementia of the Alzheimer type, presenile onset	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000225544	19	1047508 - 1047514	19	1047509 - 1047515	225544	227447	rs547447016	NC_000019.10:1047508:GGAGCAGGG:GG
NM_000484.4(APP):c.2212-9_2212-6del	APP		Alzheimer disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2021)	criteria provided, conflicting interpretations	VCV001132106	21	27254088 - 27254091	21	25881777 - 25881780	1132106	1128740		NC_000021.9:25881776:AAACAA:AA
NM_000484.4(APP):c.1078_1087delinsC (p.Asp360_Lys363delinsGln)	APP		Alzheimer disease	Uncertain significance(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000662051	21	27369678 - 27369687	21	25997363 - 25997372	662051	648880	rs1601155187	NC_000021.9:25997362:TAACAGGATC:G
NM_000484.4(APP):c.2212-11_2212-10del	APP		not provided|not specified|Alzheimer disease	Benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000585433	21	27254092 - 27254093	21	25881781 - 25881782	585433	577873	rs112965435	NC_000021.9:25881780:AA:
NM_000484.4(APP):c.2212-12_2212-10del	APP		Alzheimer disease	Likely benign(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000453313	21	27254092 - 27254094	21	25881781 - 25881783	453313	469532	rs753046287	NC_000021.9:25881780:AAGA:A
NM_000158.4(GBE1):c.2053-3358_2053-3350delinsTGTTTTTTACATGACAGGT	GBE1		Adult polyglucosan body disease|Adult polyglucosan body neuropathy	Pathogenic(Last reviewed: Apr 7, 2021)	criteria provided, single submitter	VCV000225145	3	81542964 - 81542972	3	81493813 - 81493821	225145	227045	rs869320698	NC_000003.12:81493812:CCACCACAC:ACCTGTCATGTAAAAAACA
GRN, 1-BP DEL, 154A	GRN		Grn-related frontotemporal lobar degeneration with Tdp43 inclusions	Pathogenic(Last reviewed: Feb 1, 2010)	no assertion criteria provided	VCV000016022					16022	31061		
NM_001045.5(SLC6A4):c.-1941_-1899del	LOC110806262|SLC6A4		Serotonin transporter activity, increased/decreased	Pathogenic(Last reviewed: Jun 17, 2009)	no assertion criteria provided	VCV000012934	17	28564285 - 28564327	17	30237267 - 30237309	12934	27973	rs774676466	NC_000017.11:30237266:GGGCTGCAGGGGGGATGCTGGGGGTGCAGGGGAGATGCTGGGGGGGCTGCAGGGGGGATGCTGGGGGTGCAGGGG:GGGCTGCAGGGGGGATGCTGGGGGTGCAGGGG
NC_000014.8:g.73603082del	PSEN1		Pick disease|Acne inversa, familial, 3|Frontotemporal dementia|Alzheimer disease, type 3	Benign(Last reviewed: Oct 30, 2020)	criteria provided, single submitter	VCV001168490	14	73603082	14	73136374	1168490	1157322		NC_000014.9:73136373:CCCCC:CCCC
NM_000021.4(PSEN1):c.869-1624_956-2452del	PSEN1		Alzheimer disease, type 4	Pathogenic(Last reviewed: Dec 23, 2010)	no assertion criteria provided	VCV000038296	14	73671466 - 73676021	14	73204758 - 73209313	38296	46863		
NM_000021.4(PSEN1):c.725del (p.Pro242fs)	PSEN1	P238fs, P242fs	Acne inversa, familial, 3	Pathogenic(Last reviewed: Nov 19, 2010)	no assertion criteria provided	VCV000029606	14	73659526	14	73192818	29606	38560	rs1595035030	NC_000014.9:73192817:CCC:CC
PSEN1, 3-BP DEL	PSEN1		Alzheimer disease, familial, 3, with spastic paraparesis and unusual plaques	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000018154					18154	33193		
NM_000021.4(PSEN1):c.1300_1301delinsTG (p.Ala434Cys)	PSEN1	A434C, A430C	not provided|Alzheimer disease, type 3	Pathogenic(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000018141	14	73685893 - 73685894	14	73219185 - 73219186	18141	33180	rs281875357	NC_000014.9:73219184:GC:TG
PSEN1, IVS4DS, 1-BP DEL, G	PSEN1		Alzheimer disease, type 3	Pathogenic(Last reviewed: Aug 1, 1999)	no assertion criteria provided	VCV000018140					18140	33179		
PSEN1, IVS8AS, G-T, -1	PSEN1		Alzheimer disease, familial, with spastic paraparesis and unusual plaques|Alzheimer disease, type 3	Pathogenic(Last reviewed: Mar 14, 2000)	no assertion criteria provided	VCV000018134					18134	33173		
NC_000001.11:g.(?_226881888)_(226895599_?)del	PSEN2		Alzheimer disease, type 4	Pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000533784	1	227069589 - 227083300	1	226881888 - 226895599	533784	514880		
NM_000447.3(PSEN2):c.886+2_886+4del	PSEN2		Alzheimer disease, type 4	Likely pathogenic(Last reviewed: Sep 17, 2017)	criteria provided, single submitter	VCV000465218	1	227077836 - 227077838	1	226890135 - 226890137	465218	447749	rs1553268799	NC_000001.11:226890134:TGA:
NM_020821.3(VPS13C):c.1988del (p.Thr663fs)	VPS13C	T620fs, T663fs	Primary degenerative dementia of the Alzheimer type, presenile onset	Uncertain significance(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000870545	15	62274699	15	61982500	870545	858708		NC_000015.10:61982499:G:
